-
EP3104859
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3104859
| EP3104859 - APPLICATION OF CINCHONA ALKALOID DERIVATIVES AS CYTOTOXIC COMPOUNDS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 16.06.2017 Database last updated on 04.11.2024 | |
| Former | Request for examination was made Status updated on 18.11.2016 | Most recent event Tooltip | 16.06.2017 | Withdrawal of application | published on 19.07.2017 [2017/29] | Applicant(s) | For all designated states Adam Mickiewicz University Wieniawskiego 1 61-712 Poznan / PL | [2016/51] | Inventor(s) | 01 /
CELEWICZ, Lech os. Boleslawa Chrobrego 1 m. 62 PL-60-681 Poznan / PL | 02 /
KACPRZAK, Karol Kozia 18 PL-62-053 Pecna / PL | 03 /
RUSZKOWSKI, Piotr Tarninowa 3 PL-62-002 Suchy Las / PL | [2016/51] | Representative(s) | Lisiecki, Wojciech ul. Wieniawskiego 1 61-712 Poznan / PL | [2016/51] | Application number, filing date | 14716998.1 | 04.03.2014 | [2016/51] | WO2014PL50011 | Priority number, date | PL20140407154 | 12.02.2014 Original published format: PL 40715414 | [2016/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015041551 | Date: | 26.03.2015 | Language: | EN | [2015/12] | Type: | A1 Application with search report | No.: | EP3104859 | Date: | 21.12.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.03.2015 takes the place of the publication of the European patent application. | [2016/51] | Search report(s) | International search report - published on: | EP | 26.03.2015 | Classification | IPC: | A61K31/4709, A61P35/00 | [2016/51] | CPC: |
A61K31/49 (EP,US);
A61P35/00 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/51] | Title | German: | VERWENDUNG VON CHINARINDENALKALOID-DERIVATE ALS ZYTOTOXISCHE VERBINDUNGEN | [2016/51] | English: | APPLICATION OF CINCHONA ALKALOID DERIVATIVES AS CYTOTOXIC COMPOUNDS | [2016/51] | French: | APPLICATION DE DÉRIVÉS ALCALOÏDES DE QUINQUINA EN TANT QUE COMPOSÉS CYTOTOXIQUES | [2016/51] | Entry into regional phase | 21.01.2015 | National basic fee paid | 21.01.2015 | Designation fee(s) paid | 21.01.2015 | Examination fee paid | Examination procedure | 19.02.2015 | Examination requested [2016/51] | 19.02.2015 | Date on which the examining division has become responsible | 08.06.2017 | Application withdrawn by applicant [2017/29] | Fees paid | Renewal fee | 24.03.2016 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.03.2017 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]PL215451B (POLITECHNIKA WROCLAWSKA [PL]) [A] 1-5 * claims *; | [AD]EP1477488 (DAISO CO LTD [JP]) [AD] 1-5 * [0066] * | [A] - MARTIROSYAN A R ET AL, "Differentiation-inducing quinolines as experimental breast cancer agents in the MCF-7 human breast cancer cell model", BIOCHEMICAL PHARMACOLOGY, ELSEVIER, US, (20041101), vol. 68, no. 9, doi:10.1016/J.BCP.2004.05.003, ISSN 0006-2952, pages 1729 - 1738, XP004585039 [A] 1-5 * table 1; figure 1 * DOI: http://dx.doi.org/10.1016/j.bcp.2004.05.003 | by applicant | EP1477488 | - TAGLIALATELA-SCAFATI, O. Modern Alkaloids, WILEY-VCH, (2007), page 25 | - LEE, S.-Y. ET AL., ENVIRON. TOX., (2011), vol. 26, page 424 | - SOLARY, E ET AL., LEUKEMIA, (2000), vol. 14, page 2085 | - MARTIROSYAN, A.R. ET AL., BIOCHEM. PHARMACOL., (2004), vol. 68, page 1729 | - VICHAI, V.; KIRTIKARA, K., NATURE PROTOCOLS, (2006), vol. 1, page 1112 | - Division of Cancer Treatment, Drug Research and Development. Program Procedure. Instruction and technical documentation change notice, instruction 14. Screening data summary interpretation and outline of current screening, NIH, (1980), vol. 6, pages 31 - 62 |